temozolomide has been researched along with Depressive Disorder in 2 studies
Depressive Disorder: An affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. The mood disturbance is prominent and relatively persistent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Egeland, M | 1 |
| Guinaudie, C | 1 |
| Du Preez, A | 1 |
| Musaelyan, K | 1 |
| Zunszain, PA | 1 |
| Fernandes, C | 1 |
| Pariante, CM | 1 |
| Thuret, S | 1 |
| Pérez-Domper, P | 1 |
| Palomo, V | 1 |
| Gradari, S | 1 |
| Gil, C | 1 |
| de Ceballos, ML | 1 |
| Martínez, A | 1 |
| Trejo, JL | 1 |
2 other studies available for temozolomide and Depressive Disorder
| Article | Year |
|---|---|
Depletion of adult neurogenesis using the chemotherapy drug temozolomide in mice induces behavioural and biological changes relevant to depression.
Topics: Animals; Antineoplastic Agents, Alkylating; Behavior, Animal; Biochemical Phenomena; Brain; Brain Ne | 2017 |
The GSK-3-inhibitor VP2.51 produces antidepressant effects associated with adult hippocampal neurogenesis.
Topics: Animals; Antidepressive Agents; Antimitotic Agents; Avoidance Learning; beta Catenin; Dacarbazine; D | 2017 |